These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Flumazenil, hepatic encephalopathy and benzodiazepines]. Sacristán JA; Soto J; Francis D; Sánchez R Med Clin (Barc); 1991 Mar; 96(8):317. PubMed ID: 1645830 [No Abstract] [Full Text] [Related]
7. The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands. Basile AS; Jones EA; Skolnick P Pharmacol Rev; 1991 Mar; 43(1):27-71. PubMed ID: 1674609 [No Abstract] [Full Text] [Related]
8. [Current possibilities in the therapy of hepatic encephalopathy]. Meier PJ; Bansky G Schweiz Med Wochenschr; 1990 Apr; 120(15):553-6. PubMed ID: 2159659 [TBL] [Abstract][Full Text] [Related]
10. Treatment of hepatic encephalopathy (HE) with the benzodiazepine antagonist flumazenil: a pilot study. Meier R; Gyr K Eur J Anaesthesiol Suppl; 1988; 2():139-46. PubMed ID: 2842130 [TBL] [Abstract][Full Text] [Related]
11. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure. Bassett ML; Mullen KD; Skolnick P; Jones EA Gastroenterology; 1987 Nov; 93(5):1069-77. PubMed ID: 2820828 [TBL] [Abstract][Full Text] [Related]
12. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study. Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Barbarini G Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999 [TBL] [Abstract][Full Text] [Related]
14. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans. Bansky G; Meier PJ; Riederer E; Walser H; Ziegler WH; Schmid M Gastroenterology; 1989 Sep; 97(3):744-50. PubMed ID: 2546850 [TBL] [Abstract][Full Text] [Related]
15. The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat. Bosman DK; van den Buijs CA; de Haan JG; Maas MA; Chamuleau RA Gastroenterology; 1991 Sep; 101(3):772-81. PubMed ID: 1650320 [TBL] [Abstract][Full Text] [Related]
16. [Electroencephalographic study of the effect of a benzodiazepine antagonist in hepatic encephalopathy]. Pidoux B; Zylberberg P; Valla D; Opolon P Neurophysiol Clin; 1989 Dec; 19(6):469-76. PubMed ID: 2559309 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the therapeutic effect of flumazenil in hepatic encephalopathy using cerebral cartography]. Bello Mimbrera G; García de León M; de la Torre Gutiérrez S; Montero Vázquez J; Torres Salcines J; de la Torre Fernández JM Rev Esp Enferm Apar Dig; 1989 Mar; 75(3):277-9. PubMed ID: 2499914 [TBL] [Abstract][Full Text] [Related]
18. [Clinical pharmacology of flumazenil--a benzodiazepine receptor antagonist]. Janicki P; Rewerski W Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1653-6. PubMed ID: 2855862 [No Abstract] [Full Text] [Related]